2015 Q4 Form 10-Q Financial Statement

#000094480915000014 Filed on November 09, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $276.2M $143.0M $19.77M
YoY Change 981.7% 623.38% -4.21%
Cost Of Revenue $143.2M $56.67M $11.12M
YoY Change 1103.36% 409.62% -6.96%
Gross Profit $133.0M $86.36M $8.653M
YoY Change 877.94% 898.08% -78.18%
Gross Profit Margin 48.16% 60.38% 43.76%
Selling, General & Admin $102.9M $55.25M $14.01M
YoY Change 576.97% 294.33% 3.23%
% of Gross Profit 77.37% 63.97% 161.91%
Research & Development $25.50M $18.94M $20.52M
YoY Change -8.27% -7.7% 85.09%
% of Gross Profit 19.17% 21.93% 237.11%
Depreciation & Amortization $22.10M $12.40M $3.768M
YoY Change 513.89% 229.06% 0.0%
% of Gross Profit 16.62% 14.36% 43.55%
Operating Expenses $284.1M $151.3M $67.97M
YoY Change 389.98% 122.52% 71.44%
Operating Profit -$151.1M -$8.223M -$48.20M
YoY Change 240.47% -82.94% 153.56%
Interest Expense -$6.900M $29.50M $1.300M
YoY Change -56.33% 2169.23% -103.19%
% of Operating Profit
Other Income/Expense, Net -$9.000M $46.99M -$1.459M
YoY Change 76.47% -3320.97% -96.25%
Pretax Income -$23.80M $38.77M -$49.66M
YoY Change -55.35% -178.07% -14.25%
Income Tax -$26.50M -$92.98M $294.0K
% Of Pretax Income -239.81%
Net Earnings $1.603M $128.2M -$48.67M
YoY Change -103.0% -363.51% -18.88%
Net Earnings / Revenue 0.58% 89.66% -246.14%
Basic Earnings Per Share $0.00 $0.26 -$0.11
Diluted Earnings Per Share $0.00 $0.18 -$0.11
COMMON SHARES
Basic Shares Outstanding 545.0M shares 500.6M shares 427.6M shares
Diluted Shares Outstanding 515.5M shares 427.6M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $193.6M $212.1M $118.3M
YoY Change 99.79% 79.29% -34.57%
Cash & Equivalents $193.6M $212.1M $118.3M
Short-Term Investments
Other Short-Term Assets $903.0K $2.357M $2.591M
YoY Change -78.56% -9.03% -39.8%
Inventory $39.68M $40.69M $16.66M
Prepaid Expenses
Receivables $193.9M $189.7M $21.21M
Other Receivables $15.00M $7.100M $1.900M
Total Short-Term Assets $454.1M $517.4M $163.1M
YoY Change 217.81% 217.15% -32.38%
LONG-TERM ASSETS
Property, Plant & Equipment $131.8M $126.8M $17.04M
YoY Change 703.11% 644.44% 0.05%
Goodwill $743.3M $761.2M $224.8M
YoY Change 231.42% 238.67% 1.09%
Intangibles
YoY Change
Long-Term Investments $29.40M $29.20M $21.10M
YoY Change 82.61% 38.39% -8.66%
Other Assets $4.841M $102.7M $4.673M
YoY Change -17.08% 2097.22% -33.27%
Total Long-Term Assets $2.345B $2.498B $1.132B
YoY Change 108.49% 120.69% -0.84%
TOTAL ASSETS
Total Short-Term Assets $454.1M $517.4M $163.1M
Total Long-Term Assets $2.345B $2.498B $1.132B
Total Assets $2.799B $3.016B $1.295B
YoY Change 120.81% 132.84% -6.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.54M $77.97M $8.841M
YoY Change 729.54% 781.9% -35.14%
Accrued Expenses $167.9M $201.1M $55.55M
YoY Change 175.64% 262.01% 28.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $11.47M $78.51M $12.45M
YoY Change -14.77% 530.79% -14.03%
Total Short-Term Liabilities $251.9M $357.6M $76.84M
YoY Change 203.09% 365.36% 7.66%
LONG-TERM LIABILITIES
Long-Term Debt $2.523M $4.735M $2.627M
YoY Change 3.66% 80.24% -21.58%
Other Long-Term Liabilities $292.5M $236.5M $216.2M
YoY Change 482.55% 9.39% -7.92%
Total Long-Term Liabilities $567.5M $688.9M $331.1M
YoY Change 62.69% 108.09% -25.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $251.9M $357.6M $76.84M
Total Long-Term Liabilities $567.5M $688.9M $331.1M
Total Liabilities $819.4M $1.046B $407.9M
YoY Change 89.71% 156.56% -20.81%
SHAREHOLDERS EQUITY
Retained Earnings -$704.9M -$706.5M -$621.9M
YoY Change 4.45% 13.6% 27.86%
Common Stock $5.462M $5.459M $4.329M
YoY Change 26.03% 26.1% 5.87%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.645M $3.645M $4.051M
YoY Change -10.02% -10.02% -45.68%
Treasury Stock Shares 1.120M shares 1.120M shares 1.245M shares
Shareholders Equity $1.980B $1.971B $893.3M
YoY Change
Total Liabilities & Shareholders Equity $2.799B $3.016B $1.295B
YoY Change 120.81% 132.84% -6.34%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $1.603M $128.2M -$48.67M
YoY Change -103.0% -363.51% -18.88%
Depreciation, Depletion And Amortization $22.10M $12.40M $3.768M
YoY Change 513.89% 229.06% 0.0%
Cash From Operating Activities -$9.400M -$31.30M -$21.10M
YoY Change -62.1% 48.34% 137.08%
INVESTING ACTIVITIES
Capital Expenditures -$6.400M -$8.000M -$1.400M
YoY Change 700.0% 471.43% 55.56%
Acquisitions
YoY Change
Other Investing Activities -$1.500M $15.10M $0.00
YoY Change -100.0%
Cash From Investing Activities -$7.900M $7.200M -$1.600M
YoY Change 887.5% -550.0% -103.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -200.0K 14.70M 7.100M
YoY Change -104.76% 107.04% 2266.67%
NET CHANGE
Cash From Operating Activities -9.400M -31.30M -21.10M
Cash From Investing Activities -7.900M 7.200M -1.600M
Cash From Financing Activities -200.0K 14.70M 7.100M
Net Change In Cash -17.50M -9.400M -15.60M
YoY Change -18.22% -39.74% -142.62%
FREE CASH FLOW
Cash From Operating Activities -$9.400M -$31.30M -$21.10M
Capital Expenditures -$6.400M -$8.000M -$1.400M
Free Cash Flow -$3.000M -$23.30M -$19.70M
YoY Change -87.5% 18.27% 146.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000944809
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
545011748 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Opko Health, Inc.
CY2014Q4 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
8643000 USD
CY2015Q3 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
4351000 USD
CY2014Q4 opk Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net
AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet
-3232000 USD
CY2015Q3 opk Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net
AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet
-176000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Discount Rates Increase One Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfDiscountRatesIncreaseOnePercent
-900000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent
-1800000 USD
CY2014Q4 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
0 USD
CY2015Q3 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
5000000 USD
CY2014Q4 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
1100000000 USD
CY2015Q3 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
2200000000 USD
CY2014Q3 opk Collaborative Arrangement Grant Repayment
CollaborativeArrangementGrantRepayment
0 USD
opk Collaborative Arrangement Grant Repayment
CollaborativeArrangementGrantRepayment
0 USD
CY2015Q1 opk Collaborative Arrangement Grant Repayment
CollaborativeArrangementGrantRepayment
25900000 USD
CY2015Q3 opk Collaborative Arrangement Grant Repayment
CollaborativeArrangementGrantRepayment
0 USD
opk Collaborative Arrangement Grant Repayment
CollaborativeArrangementGrantRepayment
25889000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
3494000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
14241000 USD
CY2014Q4 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
12 institution
CY2015Q3 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
10 institution
CY2015Q3 opk Equity Method Investment Excluding Variable Interest Entity
EquityMethodInvestmentExcludingVariableInterestEntity
25693000 USD
CY2015Q3 opk Equity Method Investment Variable Interest Entity
EquityMethodInvestmentVariableInterestEntity
303000 USD
CY2014Q3 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-49954000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-118690000 USD
CY2015Q3 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
131749000 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
100000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-26964000 USD
CY2014Q3 opk Interest Expense Nonoperating
InterestExpenseNonoperating
2402000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
10572000 USD
CY2015Q3 opk Interest Expense Nonoperating
InterestExpenseNonoperating
2745000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
6296000 USD
CY2014Q3 opk Interest Income Nonoperating
InterestIncomeNonoperating
402000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
450000 USD
CY2015Q3 opk Interest Income Nonoperating
InterestIncomeNonoperating
13000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
27000 USD
CY2012Q3 opk Numberof Medicare Claims Includedin Post Payment Review Audit
NumberofMedicareClaimsIncludedinPostPaymentReviewAudit
183 claim
CY2014Q4 opk Other Liabilities Deferred Revenueand Contingent Consideration Noncurrent
OtherLiabilitiesDeferredRevenueandContingentConsiderationNoncurrent
50205000 USD
CY2015Q3 opk Other Liabilities Deferred Revenueand Contingent Consideration Noncurrent
OtherLiabilitiesDeferredRevenueandContingentConsiderationNoncurrent
236476000 USD
opk Percentage Of Increase Decrease In Discount Rate
PercentageOfIncreaseDecreaseInDiscountRate
0.01
CY2015Q3 opk Percentage Of Increase Decrease In Future Sales
PercentageOfIncreaseDecreaseInFutureSales
-0.1
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
180000 USD
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
140000 USD
CY2014Q3 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
0 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
476000 USD
CY2015Q3 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
18350000 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
48552000 USD
CY2014Q3 opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
86 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
395242 shares
CY2015Q3 opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
153 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
1206807 shares
CY2014Q3 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
3556688 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
5262094 shares
CY2015Q3 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
1595614 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
25437929 shares
CY2014Q3 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
3556602 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
4866852 shares
CY2015Q3 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
1595461 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
24231123 shares
CY2015Q3 opk Stock Optionand Warrant Investments
StockOptionandWarrantInvestments
5543000 USD
CY2014Q4 opk Taxes Recoverable Current
TaxesRecoverableCurrent
2417000 USD
CY2015Q3 opk Taxes Recoverable Current
TaxesRecoverableCurrent
3083000 USD
CY2014Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
669000 USD
CY2015Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3995000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8744000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
77969000 USD
CY2014Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
21875000 USD
CY2015Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
198840000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19969000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
189725000 USD
CY2014Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4127000 USD
CY2015Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
31668000 USD
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
77000 USD
CY2015Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
24024000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60912000 USD
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
201113000 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1860000 USD
CY2015Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1375000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12392000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20992000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1529096000 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2696420000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1906000 USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9115000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1907000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1175000 USD
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2735000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8304000 USD
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8110000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14011000 USD
CY2014Q4 us-gaap Assets
Assets
1267664000 USD
CY2015Q3 us-gaap Assets
Assets
3015853000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
142869000 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
517416000 USD
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
12072000 USD
CY2015Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
8699000 USD
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
509000 USD
CY2015Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
715000 USD
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4573000 USD
CY2015Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7596000 USD
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
12904000 USD
CY2015Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
15404000 USD
CY2015Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
3156000 USD
CY2014Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19592000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
24078000 USD
CY2015Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1636000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6471000 USD
CY2014Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
71600000 USD
CY2015Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
55900000 USD
CY2014Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
27352000 USD
CY2015Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
28283000 USD
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
0 USD
CY2015Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10785000 USD
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
0 USD
CY2015Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
7120000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185798000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118258000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96907000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
212144000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
566000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1383000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-67540000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
115237000 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
433421677 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
545951707 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
4334000 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
5459000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57672000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-130810000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
126134000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40231000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1345000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2481000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1400000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-59017000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-133291000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
126134000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-41631000 USD
CY2014Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
131454000 USD
CY2015Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
44206000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8761000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
28987000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
10658000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
30650000 USD
CY2014Q3 us-gaap Cost Of Services
CostOfServices
2359000 USD
us-gaap Cost Of Services
CostOfServices
7088000 USD
CY2015Q3 us-gaap Cost Of Services
CostOfServices
56670000 USD
us-gaap Cost Of Services
CostOfServices
61434000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
17340000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-96713000 USD
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
6700000 USD
CY2015Q3 us-gaap Deferred Revenue
DeferredRevenue
254100000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4185000 USD
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
75763000 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2526000 USD
CY2015Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
178308000 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
1892000 USD
CY2015Q3 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
55527000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
167153000 USD
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
408213000 USD
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3768000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11269000 USD
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12399000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20073000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-180000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-30000 USD
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
31800000 USD
CY2015Q3 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
85900000 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
430500000 USD
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
100300000 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-64300000 USD
CY2015Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
30722000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33931000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
45966000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62649000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
660287000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1008000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-776000 USD
CY2014Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3305000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3758000 USD
CY2015Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
32244000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-34100000 USD
CY2014Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-60000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-2486000 USD
CY2015Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-3502000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-6067000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1273000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
216000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2668000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
943000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
224292000 USD
CY2015Q3 us-gaap Goodwill
Goodwill
761234000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
538021000 USD
us-gaap Goodwill Other Changes
GoodwillOtherChanges
1079000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-49660000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-117681000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
38771000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-114182000 USD
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-60000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2486000 USD
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3502000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6067000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
294000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1009000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-92978000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-87218000 USD
CY2014Q4 us-gaap Line Of Credit
LineOfCredit
7658000 USD
CY2015Q3 us-gaap Line Of Credit
LineOfCredit
77479000 USD
CY2015Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
134961000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3850000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-35504000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4140000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14012000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1666000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
36788000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
246262000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1099000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6407000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4465000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1262000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3487000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4225000 USD
CY2014Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2065000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6349000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
793152000 USD
CY2015Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
812723000 USD
us-gaap Interest Paid
InterestPaid
5222000 USD
us-gaap Interest Paid
InterestPaid
2917000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11837000 USD
CY2015Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13851000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
16604000 USD
CY2015Q3 us-gaap Inventory Net
InventoryNet
40693000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4116000 USD
CY2015Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5472000 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
639000 USD
CY2015Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
794000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1011000 USD
CY2015Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1045000 USD
us-gaap Inventory Write Down
InventoryWriteDown
773000 USD
us-gaap Inventory Write Down
InventoryWriteDown
683000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
431923000 USD
CY2015Q3 us-gaap Liabilities
Liabilities
1046485000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1267664000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3015853000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
83111000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
357590000 USD
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
348812000 USD
CY2015Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
688895000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
13455000 USD
CY2015Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
78508000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2434000 USD
CY2015Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4735000 USD
CY2014Q4 us-gaap Long Term Investments
LongTermInvestments
22453000 USD
CY2015Q3 us-gaap Long Term Investments
LongTermInvestments
34695000 USD
CY2014Q4 us-gaap Minority Interest
MinorityInterest
-6403000 USD
CY2015Q3 us-gaap Minority Interest
MinorityInterest
-1400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3134000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33176000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4876000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91284000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65618000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
173375000 USD
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1345000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2481000 USD
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1400000 USD
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-48669000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-118695000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
128247000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-31631000 USD
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-48669000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-118695000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
129026000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-31631000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1459000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4320000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
46994000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23635000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
67974000 USD
us-gaap Operating Expenses
OperatingExpenses
178953000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
151257000 USD
us-gaap Operating Expenses
OperatingExpenses
306094000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-48201000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-113361000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8223000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-90547000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14668000 USD
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19864000 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2320000 USD
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2357000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5838000 USD
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
102676000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-8600000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3169000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
-5000000 USD
CY2014Q3 us-gaap Profit Loss
ProfitLoss
-50014000 USD
us-gaap Profit Loss
ProfitLoss
-121176000 USD
CY2015Q3 us-gaap Profit Loss
ProfitLoss
128247000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4781000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1452000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5998000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8600000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
553000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5834000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6781000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-661000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2602000 USD
CY2014Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
279000 USD
CY2015Q3 us-gaap Other Inventory Supplies
OtherInventorySupplies
21119000 USD
CY2014Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
1030000 USD
CY2015Q3 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
18738000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50205000 USD
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
236476000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2764000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2044000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17482000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16734000 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
6264000 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
0 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
4596000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
2176000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
6435000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1331000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1683000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
78862000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
589000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3000000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3935000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4422000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9389000 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
74854000 USD
CY2014Q4 us-gaap Prepaid Insurance
PrepaidInsurance
968000 USD
CY2015Q3 us-gaap Prepaid Insurance
PrepaidInsurance
594000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
81000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12066000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
25180000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
19326000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
111359000 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
0 USD
us-gaap Profit Loss
ProfitLoss
-33031000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16411000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
126822000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-20000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8308000 USD
CY2015Q3 us-gaap Purchase Obligation
PurchaseObligation
19300000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
21823000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
103544000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20517000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57744000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18937000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
74010000 USD
CY2014Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10055000 USD
CY2015Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-674843000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-706474000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
17291000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
58510000 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
20765000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
59066000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
19773000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
65592000 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
143034000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
215547000 USD
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
2482000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6606000 USD
CY2015Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
103919000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
107929000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14010000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42697000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55246000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93629000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10088000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
17765000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
842144000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
1970768000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
835741000 USD
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1969368000 USD
CY2014Q4 us-gaap Supplies
Supplies
1123000 USD
CY2015Q3 us-gaap Supplies
Supplies
9298000 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1245367 shares
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1120367 shares
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4051000 USD
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3645000 USD
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
2300000 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
93400000 USD
CY2014Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
7600000 USD
CY2014Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
12100000 USD
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13758000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
427577102 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
418649421 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
514320570 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
469931486 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
427577102 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
418649421 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
500562254 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
469931486 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0000944809-15-000014-index-headers.html Edgar Link pending
0000944809-15-000014-index.html Edgar Link pending
0000944809-15-000014.txt Edgar Link pending
0000944809-15-000014-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
opk-20150930.xml Edgar Link completed
opk-20150930.xsd Edgar Link pending
opk-20150930_cal.xml Edgar Link unprocessable
opk-20150930_def.xml Edgar Link unprocessable
opk-20150930_lab.xml Edgar Link unprocessable
opk-20150930_pre.xml Edgar Link unprocessable
opk-9302015x10q.htm Edgar Link pending
opk-9302015xex231.htm Edgar Link pending
opk-9302015xex311.htm Edgar Link pending
opk-9302015xex312.htm Edgar Link pending
opk-9302015xex321.htm Edgar Link pending
opk-9302015xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending